Sector News

Lanxess acquires Chemours' disinfectants business for €210 million

April 25, 2016
Chemical Value Chain

Lanxess said on Monday that it is taking over the ‘clean and disinfect’ business of Chemours. The operation comprises active ingredients as well as specialty chemicals used in disinfectant and hygiene solutions.

One of its core products is the Virkon S branded disinfectant, that is being deployed globally in the veterinary disinfection sector and in combat against major diseases such as foot-and-mouth and avian influenza. The two companies have signed an acquisition agreement.

The enterprise value of around €210 million ($236.3 million) will be paid by Lanxess from existing liquidity, the company says. Closing is expected in the second half of 2016, subject to approvals from relevant antitrust authorities. The acquisition will be earnings per share accretive in the first fiscal year and the acquired business is expected to generate an annual Ebitda contribution of around €20 million, which will increase gradually with synergy effects to roughly €30 million by 2020.

Lanxess is taking over 170 Chemours’ employees and three production sites at Memphis and North Kingstown, Rhode Island in the United States, and Sudbury, United Kingdom. In 2015, the business achieved sales of around €100 million, roughly half of which was in North America.

The deal is Lanxess’s first acquisition after completion of its realignment program. “We plan to enhance our position particularly in mid-sized, less cyclical markets with high margins and sound growth prospects,” said Matthias Zachert, chairman of Lanxess. “We have made quick headway and are now expanding our specialty chemicals portfolio which will make us more profitable and more resilient. Through the acquisition, we will grow especially in the region of North America, where we still see good opportunities,” Zachert says. Lanxess recently hived off its synthetic rubber business, the largest producer in the world, into Arlanxeo, an equally owned joint venture with Saudi Aramco.

The acquired operation will be integrated into Lanxess’s material protection products business unit. “With the acquisition of Chemours’ clean and disinfect business, we are not only expanding our portfolio of active ingredients, but are also able to establish a forward integrated value chain in the veterinary disinfection segment,” said Michael Schäfer, head of the material protection products business unit.

The business comprises three segments: disinfectants, potassium monopersulfate and chlorine dioxide. Each segment holds leading positions worldwide and serves attractive markets that benefit from growth trends, Lanxess says. The disinfectants segment focuses on providing solutions for veterinary disinfection. Its core product is powder disinfectant marketed under the Virkon S brand and is used to combat a multitude of viruses, bacteria and fungi, particularly in combating the foot-and-mouth and swine vesicular diseases as well as avian influenza. Potassium monopersulfate, sold under its core brand of Oxone, is used for pool and spa applications, in personal care, the electronics industry and as active ingredient in the formulation of disinfection products, especially Virkon branded products. The chlorine dioxide segment is an established provider of package solutions for industrial water treatment.

Lanxess’s material protection products unit employs around 350 people and operates production sites at Krefeld-Uerdingen and Dormagen, Germany; Pittsburgh, US; Jhagadia, India; Changzhou, China; and Singapore. It forms part of the performance chemicals segment, which generated sales of roughly €2.1 billion in 2015.

By Natasha Alperowicz

Source: Chemical Week

comments closed

Related News

December 3, 2022

Corteva to acquire Stoller Group for $1.2 billion

Chemical Value Chain

Corteva (Indianapolis, Indiana) says it has signed a definitive agreement to acquire Stoller Group (Houston, Texas), a producer of biostimulants and plant nutrition products, for $1.2 billion. Stoller is one of the largest independent biologicals companies globally, with operations in more than 60 countries and more than $400 million in annual sales.

December 3, 2022

OMV introduces new corporate structure to drive sustainable growth and innovation

Chemical Value Chain

OMV has announced its new corporate structure today, designed to fully enable the delivery of Strategy 2030. The new organization will be built on five distinct areas. In addition to the CEO and CFO areas, three business segments will be established: Chemicals & Materials, Fuels & Feedstock, and Energy.

December 3, 2022

What does the current downturn in industrial manufacturing mean for executives searching for a senior role in the chemicals industry?

Chemical Value Chain

The European petchem sector is readying for some tough quarters. It’s a different picture in the US. So is this the best time ever to find a new role in the chemical industry? If you are in Europe, you would expect me to say probably not. But actually, it depends. So let me give you four answers to this question.